BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2013

Mar 8, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2013-03-06

Reporting Person: GREY MICHAEL G (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-03-03	Common Stock	M	15000	$14.39	Acquired	34650	Direct
2013-03-06	Common Stock	S	15000	$60.6090	Disposed	19650	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-03-06	Stock Option (right to buy)	$14.39	M	15000	Disposed	2019-05-11	Common Stock (15000)	Direct

Footnotes

F1: The price in Column 4 is a weighted average price. The prices actually received ranged from $60.30 to $61.20. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F2: Original option grant vests 1/4 every 90 days.

F3: Reflects the number of stock options that remain outstanding from this specific stock option grant following the reported transaction.